Camden National Corporation
NASDAQ:CACBanks - Regional
+$0.02 today
- Market cap
- $981.28M
- Beta
- 0.56
- P/E (TTM)
- 10.9
- EPS (TTM)
- $4.70
- Dividend yield
- 3.27%
Volume 0.06M
Average 0.10M
CAC Other Financing Activities
Financing cash flows not reported separately.
Camden National CorporationNASDAQ: CAC
Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026
Other financing activities turns positive
Q1 FY2026 other financing activities was $47.22M, compared with -$7.42M a year earlier. Trailing-twelve-month other financing activities was -$12.64M.
Context
- Other financing activities amounted to 18.3% of revenue in FY2025, up 6.1 pp from a year earlier.
- Other financing activities increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near $47.22M or moves back toward the trailing-twelve-month quarterly average of -$3.16M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (67.29M) USD
- Year-over-year change
- -290.4%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (67.29M) | -290.4% |
| FY2024 | 2024-12-31 | 35.34M | +115.4% |
| FY2023 | 2023-12-31 | (229.83M) | -205.6% |
| FY2022 | 2022-12-31 | 217.69M | -63.9% |
| FY2021 | 2021-12-31 | 603.38M | — |
Other Financing Activities vs competitors
How CAC compares with its peers on the latest reported figures
- CAC's LTM Mar 2026 other financing activities of $12.64M is the 8th largest of the 11 companies compared; the peer median is $10.82M.
- Its year-over-year change of -117.1% is the 9th highest of 11, against a peer median of -43.5%.
- Other financing activities amounts to 3.5% of revenue for CAC, versus a peer median of 15.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $382.71M | +24.5% | +135.7% | 101.2% | |
| LTM Mar 2026 | $314.32M | -25.6% | — | 72.1% | |
| LTM Mar 2026 | $82.86M | +19.6% | +16.7% | 66.8% | |
| LTM Mar 2026 | $41.33M | -81.9% | -17.0% | 20.0% | |
| LTM Mar 2026 | $32.27M | -125.0% | — | 11.7% | |
| LTM Mar 2026 | $28.11M | +83.3% | — | 32.7% | |
| LTM Mar 2026 | $14.16M | -61.4% | -28.3% | 7.2% | |
| LTM Mar 2026 | $12.64M | -117.1% | — | 3.5% | |
| LTM Mar 2026 | $12.55M | +9.6% | -21.0% | 10.8% | |
| LTM Mar 2026 | $7.49M | -434.0% | — | 9.0% | |
| LTM Mar 2026 | $3.23M | -103.0% | — | 2.0% | |
| Peer median (excluding CAC) | $10.82M | -43.5% | -17.0% | 15.9% | |
Competitors are the stored peer set for CAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 69.01M | 61.44M | 43.38M | 53M | 65.16M |
| Depreciation & Amortization | 4.36M | 4.12M | 3.96M | 3.87M | 11.1M |
| Deferred Income Tax | (637K) | 1.79M | 1.31M | 298K | 616K |
| Stock-Based Compensation | 2.38M | 2.55M | 2.79M | 2.9M | 3.42M |
| Change in Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Other Non-Cash Items | 64.31M | 39.98M | 9.68M | 514K | (604K) |
| Operating Cash Flow | 142.72M | 105.18M | 67.51M | 60.93M | 63.91M |
| Capital Expenditures | (1.85M) | (2.18M) | (2.62M) | (5.58M) | (5.71M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 48.26M |
| Purchases of Investments | (758.85M) | (138.17M) | (137.13M) | (60.39M) | (240.46M) |
| Sales of Investments | 321.63M | 233.67M | 225.13M | 123.06M | 209.09M |
| Other Investing Activities | (210.02M) | (581.04M) | (92.41M) | (26.76M) | (67.6M) |
| Investing Cash Flow | (649.09M) | (487.72M) | (7.03M) | 30.33M | (56.41M) |
| Debt Repayment | 9.02M | 53.41M | 220.26M | 14.73M | (28.68M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | (537K) |
| Common Stock Repurchased | (10.09M) | (10.24M) | (2M) | (1.61M) | 0 |
| Dividends Paid | (21.08M) | (23.51M) | (24.54M) | (24.56M) | (28.47M) |
| Other Financing Activities | 603.38M | 217.69M | (229.83M) | 35.34M | (67.29M) |
| Financing Cash Flow | 581.23M | 237.34M | (36.1M) | 23.9M | (124.97M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 74.85M | (145.2M) | 24.38M | 115.16M | (117.47M) |
| Free Cash Flow | 140.86M | 103M | 64.89M | 55.36M | 58.2M |
Camden National Corporation
NASDAQ:CAC
Intrinsic Alpha fair value
Locked
Current Price
$58.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.